Federico Moretti

7PUBLICATIONS
45CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 05, 2026
Validation of ICC hierarchical classification in secondary AML.

Enrico Attardi, Marta Cipriani, Luca Guarnera

|Feb 24, 2026
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Jan 28, 2026
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients.

Elisa Buzzatti, Cristina Mauro, Cristiano Tesei

|Dec 05, 2025
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

Raffaele Palmieri, Fabio Guolo, Luana Fianchi

|Jun 26, 2025
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy.

Elisa Buzzatti, Giovangiacinto Paterno, Raffaele Palmieri

|Feb 25, 2023
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML.

Elisa Meddi, Arianna Savi, Federico Moretti

Pageof 2

Frequent Collaborators

6 joint publications

Raffaele Palmieri

6 joint publications

Francesco Buccisano

6 joint publications

Adriano Venditti

4 joint publications

Luca Maurillo